3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
3
Breast
3
Other
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Conditions
Melanoma
147
Carcinoma, Non-Small-Cell Lung
34
Skin Neoplasms
28
Colorectal Neoplasms
28
Breast Neoplasms
25
Lung Neoplasms
24
Carcinoma, Renal Cell
21
Ovarian Neoplasms
20
Neoplasms
20
Squamous Cell Carcinoma of Head and Neck
19
Carcinoma, Basal Cell
19
Carcinoma, Merkel Cell
18
Sarcoma
17
Prostatic Neoplasms
17
Pancreatic Neoplasms
16
Neoplasm Metastasis
15
Head and Neck Neoplasms
14
Stomach Neoplasms
13
Thyroid Neoplasms
12
Uterine Cervical Neoplasms
11
Urinary Bladder Neoplasms
11
Carcinoma, Hepatocellular
11
Lymphoma, T-Cell, Cutaneous
10
Esophageal Neoplasms
10
Carcinoma, Transitional Cell
9
Uveal Melanoma
8
Triple Negative Breast Neoplasms
8
Mycosis Fungoides
8
Colonic Neoplasms
8
Small Cell Lung Carcinoma
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Diabetes Mellitus, Type 2
×
Dermatologic
×
30 days
×
Clear all
NCT04726319
2026-05-06
FHAMe
University of Toronto
Phase NA
Completed
627 enrolled